Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

57 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Introduction of continuous glucose monitoring (CGM) is a key factor in decreasing HbA1c in war refugee children with type 1 diabetes.
Neuman V, Vavra D, Drnkova L, Pruhova S, Plachy L, Kolouskova S, Obermannova B, Amaratunga SA, Konecna P, Vyzralkova J, Venhacova P, Pomahacova R, Paterova P, Stichova L, Skvor J, Kocourkova K, Romanova M, Vosahlo J, Strnadel J, Polockova K, Neumann D, Slavenko M, Sumnik Z. Neuman V, et al. Among authors: strnadel j. Diabetes Res Clin Pract. 2024 Feb;208:111118. doi: 10.1016/j.diabres.2024.111118. Epub 2024 Feb 1. Diabetes Res Clin Pract. 2024. PMID: 38309536
Five years of improving diabetes control in Czech children after the establishment of the population-based childhood diabetes register ČENDA.
Šumník Z, Venháčová J, Škvor J, Pomahačová R, Konečná P, Neumann D, Vosáhlo J, Strnadel J, Čížek J, Obermannová B, Petruželková L, Průhová Š, Pavlíková M, Cinek O; ČENDA Project Group. Šumník Z, et al. Among authors: strnadel j. Pediatr Diabetes. 2020 Feb;21(1):77-87. doi: 10.1111/pedi.12929. Epub 2019 Oct 16. Pediatr Diabetes. 2020. PMID: 31605416
Use of continuous glucose monitoring and its association with type 1 diabetes control in children over the first 3 years of reimbursement approval: Population data from the ČENDA registry.
Šumník Z, Pavlíková M, Pomahačová R, Venháčová P, Petruželková L, Škvor J, Neumann D, Vosáhlo J, Konečná P, Čížek J, Strnadel J, Průhová Š, Cinek O; ČENDA Project Group. Šumník Z, et al. Among authors: strnadel j. Pediatr Diabetes. 2021 May;22(3):439-447. doi: 10.1111/pedi.13184. Epub 2021 Feb 17. Pediatr Diabetes. 2021. PMID: 33533545
Type 1 diabetes incidence increased during the COVID-19 pandemic years 2020-2021 in Czechia: Results from a large population-based pediatric register.
Cinek O, Slavenko M, Pomahačová R, Venháčová P, Petruželková L, Škvor J, Neumann D, Vosáhlo J, Konečná P, Kocourková K, Strnadel J, Průhová Š, Šumník Z; ČENDA Register. Cinek O, et al. Among authors: strnadel j. Pediatr Diabetes. 2022 Nov;23(7):956-960. doi: 10.1111/pedi.13405. Epub 2022 Sep 5. Pediatr Diabetes. 2022. PMID: 35982508 Free PMC article.
Glycemic Control by Treatment Modalities: National Registry-Based Population Data in Children and Adolescents with Type 1 Diabetes.
Šumnik Z, Pavlíková M, Neuman V, Petruželková L, Konečná P, Venháčová P, Škvor J, Pomahačová R, Neumann D, Vosáhlo J, Strnadel J, Kocourková K, Obermannová B, Šantová A, Plachý L, Průhová S, Cinek O; ČENDA Project Group. Šumnik Z, et al. Among authors: strnadel j. Horm Res Paediatr. 2024;97(1):70-79. doi: 10.1159/000530833. Epub 2023 Apr 26. Horm Res Paediatr. 2024. PMID: 37100041 Free article.
Are all HCL systems the same? long term outcomes of three HCL systems in children with type 1 diabetes: real-life registry-based study.
Santova A, Plachy L, Neuman V, Pavlikova M, Petruzelkova L, Konecna P, Venhacova P, Skvor J, Pomahacova R, Neumann D, Vosahlo J, Strnadel J, Kocourkova K, Obermannova B, Pruhova S, Cinek O, Sumnik Z. Santova A, et al. Among authors: strnadel j. Front Endocrinol (Lausanne). 2023 Oct 16;14:1283181. doi: 10.3389/fendo.2023.1283181. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37908748 Free PMC article.
The Longer, the Better: Continuous Glucose Monitoring Use for ≥90% Is Superior to 70%-89% in Achieving Tighter Glycemic Outcomes in Children with Type 1 Diabetes.
Santova A, Neuman V, Plachy L, Amaratunga SA, Pavlikova M, Romanova M, Konecna P, Neumann D, Kocourkova K, Strnadel J, Pomahacova R, Venhacova P, Skvor J, Obermannova B, Pruhova S, Cinek O, Sumnik Z; ČENDA Project Group. Santova A, et al. Among authors: strnadel j. Diabetes Technol Ther. 2025 Jan 6. doi: 10.1089/dia.2024.0472. Online ahead of print. Diabetes Technol Ther. 2025. PMID: 39761072
Teplizumab and β-Cell Function in Newly Diagnosed Type 1 Diabetes.
Ramos EL, Dayan CM, Chatenoud L, Sumnik Z, Simmons KM, Szypowska A, Gitelman SE, Knecht LA, Niemoeller E, Tian W, Herold KC; PROTECT Study Investigators. Ramos EL, et al. N Engl J Med. 2023 Dec 7;389(23):2151-2161. doi: 10.1056/NEJMoa2308743. Epub 2023 Oct 18. N Engl J Med. 2023. PMID: 37861217 Clinical Trial.
57 results